A clinical pharmacokinetic study comparing two azelastine hydrochloride nasal formulations in a single-dose design
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmacology
Link
http://link.springer.com/content/pdf/10.1007/s13318-013-0134-0.pdf
Reference13 articles.
1. Bousquet J, Khaltaev N, Cruz AA et al (2008) Allergic rhinitis and its impact on asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy 63:8–160
2. Casale TB (1989) The interaction of azelastine with human lung histamine H1, beta, and muscarinic receptor binding sites. J Allergy Clin Immunol 83:771–776
3. Cawello W (1999) Parameters for compartment-free pharmacokinetics. Shaker, Aachen
4. Chand N, Pillar J, Nolan K, Diamantis W, Sofia RD (1989) Inhibition of allergic and nonallergic leukotriene C4 formation and histamine secretion by azelastine: implications for its mechanism of action. Int Arch Allergy Appl Immunol 90:67–70
5. Ciprandi G, Pronzato C, Passalacqua G et al (1996) Topical azelastine reduces eosinophil activation and intercellular adhesion molecule-I expression on nasal epithelial cells: an anti-allergic activity. J Allergy Clin Immunol 98:1088–1096
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Pharmacometric Modeling of the Impact of Azelastine Nasal Spray on SARS-CoV-2 Viral Load and Related Symptoms in COVID-19 Patients;Pharmaceutics;2022-09-27
2. Pharmacokinetics and Bioequivalence of a Generic and a Branded Budesonide Nasal Spray in Healthy Chinese Subjects;Clinical Pharmacology in Drug Development;2021-11-16
3. 10th Anniversary of a Two-Stage Design in Bioequivalence. Why Has it Still Not Been Implemented?;Pharmaceutical Research;2020-07
4. Pharmacokinetics of intranasal olopatadine in the fixed-dose combination GSP301 versus two monotherapy intranasal olopatadine formulations;Allergy and Asthma Proceedings;2018-05-01
5. Two-stage designs in bioequivalence trials;European Journal of Clinical Pharmacology;2015-01-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3